Systemic and organ-specific autoantibodies and worse outcomes in autoimmune encephalitis: a multicenter cohort study
SAOS-Ab is a prevalent and clinically relevant biomarker in AE, associated with distinct immunologic profiles, more severe disease, and significantly increased relapse risk. These findings support the integration of SAOS-Ab testing into AE management to facilitate early risk stratification and more frequent follow-up.
Authors
- Wenna Chen (ORCID: https://orcid.org/0000-0001-8824-6926)
- Yajing Cheng (ORCID: https://orcid.org/0000-0002-9851-1559)
- Yang Tai (ORCID: https://orcid.org/0000-0001-8847-5075)
- Xin Zhao (ORCID: https://orcid.org/0000-0003-2809-3221)
- Ganqin Du
- Run Song
- Ningning Wang
- Yaopeng Li
- Jing Wang
- Teng Yao
Institutions
- Capital Medical University (CN)
- Tianjin Medical University General Hospital (CN)
- First Affiliated Hospital of Henan University of Science and Technology (CN)
- Gaozhou People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.3389/fimmu.2026.1759213
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00